BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17350094)

  • 1. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
    Lindner SE; Sugden B
    Plasmid; 2007 Jul; 58(1):1-12. PubMed ID: 17350094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV's plasmid replicon: an enigma in cis and trans.
    Sugden B; Leight ER
    Curr Top Microbiol Immunol; 2001; 258():3-11. PubMed ID: 11443865
    [No Abstract]   [Full Text] [Related]  

  • 7. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin.
    Little RD; Schildkraut CL
    Mol Cell Biol; 1995 May; 15(5):2893-903. PubMed ID: 7739569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
    Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
    J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential elements of a licensed, mammalian plasmid origin of DNA synthesis.
    Wang J; Lindner SE; Leight ER; Sugden B
    Mol Cell Biol; 2006 Feb; 26(3):1124-34. PubMed ID: 16428463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of translesion synthesis on leading and lagging DNA strands in plasmids derived from Epstein-Barr virus in human cells.
    Yoon JH; Prakash S; Prakash L
    mBio; 2012; 3(5):e00271-12. PubMed ID: 22967980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
    Noguchi K
    Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication.
    Middleton T; Sugden B
    J Virol; 1992 Jan; 66(1):489-95. PubMed ID: 1309258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
    Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
    Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    Wysokenski DA; Yates JL
    J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Yates JL; Warren N; Sugden B
    Nature; 1985 Feb 28-Mar 6; 313(6005):812-5. PubMed ID: 2983224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.